1. Home
  2. CE vs AMRX Comparison

CE vs AMRX Comparison

Compare CE & AMRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Celanese Corporation

CE

Celanese Corporation

HOLD

Current Price

$42.48

Market Cap

4.4B

Sector

Industrials

ML Signal

HOLD

Logo Amneal Pharmaceuticals Inc.

AMRX

Amneal Pharmaceuticals Inc.

HOLD

Current Price

$12.50

Market Cap

3.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CE
AMRX
Founded
1918
2002
Country
United States
United States
Employees
N/A
N/A
Industry
Major Chemicals
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.4B
3.8B
IPO Year
2005
N/A

Fundamental Metrics

Financial Performance
Metric
CE
AMRX
Price
$42.48
$12.50
Analyst Decision
Buy
Buy
Analyst Count
18
4
Target Price
$57.33
$13.25
AVG Volume (30 Days)
2.1M
1.7M
Earning Date
11-06-2025
10-30-2025
Dividend Yield
0.28%
N/A
EPS Growth
N/A
N/A
EPS
N/A
0.02
Revenue
$9,710,000,000.00
$2,934,959,000.00
Revenue This Year
N/A
$9.99
Revenue Next Year
$0.62
$6.67
P/E Ratio
N/A
$758.81
Revenue Growth
N/A
9.50
52 Week Low
$35.13
$6.69
52 Week High
$75.84
$12.68

Technical Indicators

Market Signals
Indicator
CE
AMRX
Relative Strength Index (RSI) 56.87 63.33
Support Level $39.55 $12.12
Resistance Level $45.02 $12.43
Average True Range (ATR) 1.86 0.31
MACD 0.38 -0.03
Stochastic Oscillator 58.31 81.43

Price Performance

Historical Comparison
CE
AMRX

About CE Celanese Corporation

Celanese is one of the world's largest producers of acetic acid and its downstream derivative chemicals, which are used in various end markets, including coatings and adhesives. The company is also one of the largest producers of specialty polymers, which are used in the automotive, electronics, medical, building, and consumer end markets. The company also makes cellulose derivatives used in cigarette filters.

About AMRX Amneal Pharmaceuticals Inc.

Amneal Pharmaceuticals Inc is a pharmaceutical company operating in the U.S., India, and Ireland. With three reportable segments; Affordable Medicines, Specialty, and AvKARE - It develops, manufactures, and distributes a diverse portfolio of essential medicines. The Affordable Medicines segment focuses on a wide range of dosage forms and delivery systems, contributing significantly to revenues. The Specialty segment promotes proprietary branded pharmaceuticals, particularly targeting the central nervous system and endocrine disorders. The AvKARE segment provides pharmaceuticals and medical products to governmental agencies, specializing in re-packaging and wholesale distribution, with a focus on offering consistent care and pricing to qualified entities.

Share on Social Networks: